86 related articles for article (PubMed ID: 9054702)
1. The microvasculature in myeloproliferative disease. A study using retinal fluorescein angiography.
Dapling RB; Snowden JA; West J; Talbot JF; Nelson ME; Greaves M
Clin Lab Haematol; 1996 Dec; 18(4):277-9. PubMed ID: 9054702
[TBL] [Abstract][Full Text] [Related]
2. Bilateral retinal vascular occlusive disease in essential thrombocythemia.
Liu M; Lee AG; Rice L; Lambert HM
Retina; 1999; 19(6):563-4. PubMed ID: 10606460
[No Abstract] [Full Text] [Related]
3. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
Ryningen A; Apelseth T; Hausken T; Bruserud Ø
Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of fluorescein angiogram in chronic myeloproliferative disorders].
Nagasawa N
Nippon Ganka Gakkai Zasshi; 1984 Jul; 88(7):1035-42. PubMed ID: 6496246
[No Abstract] [Full Text] [Related]
5. [What vascular events suggest a myeloproliferative disorder?].
Hachulla E; Rose C; Trillot N; Caulier-Leleu MT; Pasturel-Michon U
J Mal Vasc; 2000 Dec; 25(5):382-387. PubMed ID: 11148402
[TBL] [Abstract][Full Text] [Related]
6. Combined plateletpheresis and cytotoxic chemotherapy for symptomatic thrombocytosis in myeloproliferative disorders.
Baron BW; Mick R; Baron JM
Cancer; 1993 Aug; 72(4):1209-18. PubMed ID: 8339212
[TBL] [Abstract][Full Text] [Related]
7. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
[No Abstract] [Full Text] [Related]
8. [Anagrelide in control of myeloproliferative thrombocythemia: long-term experiences in 6 patients].
Burkhard R; Adam H; Widmer L; Honegger HP
Schweiz Med Wochenschr; 1998 Nov; 128(46):1808-12. PubMed ID: 9857387
[TBL] [Abstract][Full Text] [Related]
9. The management of elderly patients with myeloproliferative disorders.
Tura S
Hematol Oncol; 1993; 11 Suppl 1():39-41. PubMed ID: 8486340
[No Abstract] [Full Text] [Related]
10. The spectrum of superficial and deep capillary ischemia in retinal artery occlusion.
Yu S; Pang CE; Gong Y; Freund KB; Yannuzzi LA; Rahimy E; Lujan BJ; Tabandeh H; Cooney MJ; Sarraf D
Am J Ophthalmol; 2015 Jan; 159(1):53-63.e1-2. PubMed ID: 25244976
[TBL] [Abstract][Full Text] [Related]
11. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
[TBL] [Abstract][Full Text] [Related]
12. Platelet and plasma beta thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis.
Boughton BJ; Allington MJ; King A
Br J Haematol; 1978 Sep; 40(1):125-32. PubMed ID: 81681
[TBL] [Abstract][Full Text] [Related]
13. Recurrent refractory arterial thromboembolism associated with the Janus kinase 2 V617F mutation.
Ali FR; Roberts LN; Mistry H; Patel RK; Edmondson RA; Arya R
J Vasc Surg; 2009 Jan; 49(1):211-3. PubMed ID: 19174256
[TBL] [Abstract][Full Text] [Related]
14. [Platelet function in chronic myeloproliferative syndromes associated with thrombocytosis].
Grebe G; Pereira J; Mezzano D; Legues ME; Aranda E; Lira P
Rev Med Chil; 1985 Jan; 113(1):32-7. PubMed ID: 4081383
[No Abstract] [Full Text] [Related]
15. [Acute retinal ischemia during carotid angiography in ophthalmic artery occlusion].
Hauke P; Zeumer H
Nervenarzt; 1975 Nov; 46(11):656-8. PubMed ID: 1202372
[No Abstract] [Full Text] [Related]
16. Anagrelide: a new drug for treating thrombocytosis.
Silverstein MN; Petitt RM; Solberg LA; Fleming JS; Knight RC; Schacter LP
N Engl J Med; 1988 May; 318(20):1292-4. PubMed ID: 3362187
[TBL] [Abstract][Full Text] [Related]
17. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
18. Long-term interferon therapy for thrombocytosis in myeloproliferative diseases.
Gisslinger H; Ludwig H; Linkesch W; Chott A; Fritz E; Radaszkiewicz T
Lancet; 1989 Mar; 1(8639):634-7. PubMed ID: 2564458
[TBL] [Abstract][Full Text] [Related]
19. Platelet function after busulphan in chronic myeloproliferative disorders.
Barbui T; Bassan R; Viero P; Cortelazzo S; Dini E
Haematologica; 1983; 68(4):469-77. PubMed ID: 6414897
[No Abstract] [Full Text] [Related]
20. Oral fluorescein angiography with the confocal scanning laser ophthalmoscope.
Garcia CR; Rivero ME; Bartsch DU; Ishiko S; Takamiya A; Fukui K; Hirokawa H; Clark T; Yoshida A; Freeman WR
Ophthalmology; 1999 Jun; 106(6):1114-8. PubMed ID: 10366079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
